Akari Therapeutics Plc — Form D

Akari Therapeutics Plc of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-12. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (52)

Showing 25 of 52 people.

NameRoleLocation
Dov ElefantDirectorSuwanee, GA
Dov ElefantExecutive OfficerSuwanee, GA
Ray PrudoExecutive OfficerTAMPA, FL
James HillDirectorAurora, CO
Samir PatelDirectorTAMPA, FL
Samir PatelRelated PersonTAMPA, FL
Sandip PatelDirectorTAMPA, FL
Sandip PatelRelated PersonTAMPA, FL
Ray PrudoDirectorTAMPA, FL
Ray PrudoRelated PersonTAMPA, FL
Hoyoung HuhDirectorTAMPA, FL
Hoyoung HuhRelated PersonTAMPA, FL
Kameel FaragExecutive OfficerTAMPA, FL
Kameel FaragRelated PersonTAMPA, FL
Rob BazemoreDirectorTAMPA, FL
Rob BazemoreRelated PersonTAMPA, FL
Abizer GaslightwalaDirectorTAMPA, FL
Abizer GaslightwalaExecutive OfficerTAMPA, FL
Abizer GaslightwalaRelated PersonTAMPA, FL
Jim NealDirectorTAMPA, FL
Jim NealRelated PersonTAMPA, FL
Allan ShawDirectorResearch Triangle Park, NC
Yuval CohenDirectorHerzliya Pituach, L3
Yuval CohenExecutive OfficerHerzliya Pituach, L3
Mark CohenDirectorBay Harbor Islands, FL

Other filings by this issuer (13)

FiledFormOfferingSold
2026-06-03D$5.5M$1.8M
2025-10-24D$6.3M$6.3M
2024-01-09D$2.0M$2.0M
2023-10-19D$2.0M$2.0M
2022-09-27D$12.8M$12.8M
2021-07-22D$12.3M$12.3M
2020-03-11D$9.6M$9.6M
2015-09-28D$75.0M$75.0M
2013-09-30D$12.5M$12.5M
2013-02-01D$10.0M$931K
2012-12-13D/A$1.5M$1.5M
2012-12-12D$1.5M$1.5M
2012-04-13D$1.1M

More